Axogen (AXGN) Income from Continuing Operations (2010 - 2026)
Axogen's (AXGN) quarterly Income from Continuing Operations came in at 2758000.0 in Q1 2026, up 24.21% year-on-year from 2220434.07 in Q1 2025, and up 74.7% quarter-over-quarter from 10900000.0 in Q4 2025.
Axogen (AXGN) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Axogen's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 2758000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 24.21% year-over-year to 2758000.0 in Q1 2026; TTM through Mar 2026 was 13349000.0, a 67.28% decrease from a year earlier, with the FY2025 full-year figure at 67579000.0, down 6.25% from the prior year.
- Income from Continuing Operations climbed to 2758000.0 in Q1 2026 per AXGN's latest filing, from 10900000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 474000.0 in Q3 2025 and bottomed at 12553000.0 in Q1 2022.
- The 5-year median for Income from Continuing Operations is 5300000.0 (2023), against an average of 5346764.71.
- Biggest YoY gain for Income from Continuing Operations was 124.78% in 2025; the steepest drop was 25852.38% in 2025.
- Year by year, Income from Continuing Operations stood at 4547000.0 in 2022, then tumbled by 97.25% to 8969000.0 in 2023, then jumped by 99.53% to 42000.0 in 2024, then slumped by 25852.38% to 10900000.0 in 2025, then soared by 74.7% to 2758000.0 in 2026.
- Per Business Quant, the three latest AXGN Income from Continuing Operations figures stand at 2758000.0 (Q1 2026), 10900000.0 (Q4 2025), and 474000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | -2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.76 Mn |
| Dec 31, 2025 | -10.90 Mn |
| Sep 30, 2025 | 474,000.00 |
| Jun 30, 2025 | -165,000.00 |
| Mar 31, 2025 | -3.64 Mn |
| Dec 31, 2024 | -42,000.00 |
| Sep 30, 2024 | -1.91 Mn |
| Jun 30, 2024 | -2.39 Mn |
| Mar 31, 2024 | -6.59 Mn |
| Dec 31, 2023 | -8.97 Mn |
| Sep 30, 2023 | -5.30 Mn |
| Jun 30, 2023 | -8.27 Mn |
| Mar 31, 2023 | -8.32 Mn |
| Dec 31, 2022 | -4.55 Mn |
| Sep 30, 2022 | -5.92 Mn |
| Jun 30, 2022 | -9.09 Mn |
| Mar 31, 2022 | -12.55 Mn |
| Dec 31, 2021 | -5.27 Mn |
| Sep 30, 2021 | -7.89 Mn |
| Jun 30, 2021 | -7.97 Mn |